Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Neriman Gokden

Concepts (346)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Neoplasms
13
2021
174
2.620
 Why?
Carcinoma, Renal Cell
13
2021
101
2.280
 Why?
Kidney Diseases
8
2020
213
1.160
 Why?
Immunohistochemistry
14
2021
975
1.120
 Why?
PAX2 Transcription Factor
4
2010
22
1.060
 Why?
Kidney Tubules
7
2021
61
1.030
 Why?
Kidney
13
2024
686
0.880
 Why?
Immunoglobulin Light Chains
4
2017
82
0.800
 Why?
Neoplasms, Complex and Mixed
1
2020
2
0.720
 Why?
Rhabdoid Tumor
1
2020
12
0.710
 Why?
Stromal Cells
1
2020
72
0.690
 Why?
Soft Tissue Neoplasms
1
2020
56
0.670
 Why?
Immune Complex Diseases
2
2008
6
0.580
 Why?
Sepsis
7
2014
227
0.550
 Why?
Mitogen-Activated Protein Kinases
2
2008
154
0.500
 Why?
Acute Kidney Injury
7
2013
295
0.470
 Why?
Adenoma
2
2021
112
0.440
 Why?
Adenoma, Oxyphilic
2
2010
11
0.430
 Why?
Carcinoma, Papillary
2
2010
49
0.420
 Why?
Male
37
2024
25718
0.400
 Why?
Renal Circulation
5
2013
59
0.380
 Why?
Prostatic Neoplasms
5
2010
394
0.380
 Why?
Proteinuria
2
2010
40
0.370
 Why?
Middle Aged
25
2021
12460
0.370
 Why?
Glomerulonephritis, IGA
1
2010
5
0.360
 Why?
Podocytes
1
2010
19
0.360
 Why?
Humans
43
2023
50389
0.360
 Why?
Microcirculation
5
2014
72
0.350
 Why?
Nephrectomy
2
2010
81
0.350
 Why?
Antigens, Neoplasm
2
2008
146
0.340
 Why?
Microscopy, Electron, Transmission
5
2014
75
0.340
 Why?
Neurofibromatosis 2
1
2009
8
0.330
 Why?
DNA Glycosylases
1
2008
19
0.310
 Why?
Adult
19
2023
13568
0.300
 Why?
Renal Insufficiency
4
2013
108
0.300
 Why?
Lymph Nodes
1
2010
258
0.300
 Why?
Plasmacytoma
2
2020
40
0.290
 Why?
Kidney Glomerulus
1
2008
39
0.290
 Why?
DNA Repair
1
2008
186
0.280
 Why?
Hypercalcemia
1
2007
33
0.280
 Why?
Diagnosis, Differential
6
2021
1042
0.280
 Why?
Female
24
2023
26981
0.270
 Why?
Alphapapillomavirus
1
2006
13
0.270
 Why?
Sensitivity and Specificity
5
2011
875
0.270
 Why?
Carcinoma
2
2020
139
0.270
 Why?
Bone Density Conservation Agents
1
2007
74
0.270
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2006
60
0.270
 Why?
Glomerulosclerosis, Focal Segmental
1
2006
13
0.260
 Why?
Urinary Bladder Neoplasms
3
2014
158
0.260
 Why?
Diphosphonates
1
2007
90
0.260
 Why?
DNA, Viral
1
2006
133
0.260
 Why?
Imidazoles
1
2007
128
0.260
 Why?
Hepatitis B
1
2006
23
0.260
 Why?
Prostatic Intraepithelial Neoplasia
2
2005
8
0.260
 Why?
Biopsy
6
2020
592
0.250
 Why?
Skin Neoplasms
2
2018
487
0.250
 Why?
Adenocarcinoma
2
2010
402
0.240
 Why?
Neoplasms, Multiple Primary
1
2005
43
0.240
 Why?
Paraproteinemias
2
2016
72
0.220
 Why?
Predictive Value of Tests
5
2021
934
0.220
 Why?
Aged, 80 and over
8
2017
3180
0.220
 Why?
Pheochromocytoma
1
2023
36
0.220
 Why?
Adrenal Gland Neoplasms
1
2023
51
0.220
 Why?
Proteasome Endopeptidase Complex
1
2024
116
0.210
 Why?
Aged
13
2021
9590
0.210
 Why?
Dermatofibrosarcoma
1
2003
8
0.210
 Why?
Oncogene Proteins, Fusion
1
2003
59
0.210
 Why?
Kidney Transplantation
1
2024
182
0.190
 Why?
Cisplatin
3
2012
275
0.190
 Why?
Kidney Diseases, Cystic
1
2021
19
0.190
 Why?
Immunoglobulin G
2
2014
185
0.180
 Why?
Multiple Myeloma
3
2017
2949
0.180
 Why?
Precancerous Conditions
1
2021
83
0.180
 Why?
Carcinoma, Transitional Cell
2
2012
52
0.170
 Why?
Qb-SNARE Proteins
1
2019
6
0.170
 Why?
Qc-SNARE Proteins
1
2019
10
0.170
 Why?
Actin Cytoskeleton
1
2019
22
0.170
 Why?
Hepatic Stellate Cells
1
2019
17
0.170
 Why?
Antineoplastic Agents
3
2017
1178
0.170
 Why?
Neoplasms, Plasma Cell
1
2020
37
0.170
 Why?
Myofibroblasts
1
2019
49
0.160
 Why?
Kidney Failure, Chronic
1
2021
200
0.160
 Why?
Cell Nucleus
2
2010
186
0.160
 Why?
Neoplasm Metastasis
2
2010
235
0.160
 Why?
Myoblasts
1
2018
18
0.150
 Why?
Melanoma
2
2018
281
0.140
 Why?
Synovitis
1
2017
21
0.140
 Why?
Capillaries
4
2014
52
0.140
 Why?
Eosinophilia
1
2017
36
0.140
 Why?
Cell Proliferation
1
2021
989
0.140
 Why?
Retrospective Studies
5
2012
6223
0.140
 Why?
DNA, Neoplasm
3
2008
146
0.140
 Why?
Angiomyolipoma
1
2016
10
0.130
 Why?
Thoracic Neoplasms
1
2016
13
0.130
 Why?
Tuberous Sclerosis
1
2016
36
0.130
 Why?
Mice
11
2019
5688
0.130
 Why?
Tumor Suppressor Proteins
1
2016
127
0.120
 Why?
Antibodies, Monoclonal, Humanized
1
2017
224
0.120
 Why?
Animals
14
2024
13173
0.120
 Why?
Receptors, Lysosphingolipid
1
2014
5
0.120
 Why?
Reactive Nitrogen Species
3
2011
23
0.120
 Why?
Urothelium
1
2014
18
0.120
 Why?
Hemangiosarcoma
1
2014
16
0.120
 Why?
Neoplasm Staging
3
2014
750
0.110
 Why?
Immunoglobulin kappa-Chains
1
2014
22
0.110
 Why?
Necrosis
2
2012
175
0.110
 Why?
Glomerulonephritis, Membranous
1
2014
27
0.110
 Why?
Rolipram
1
2013
2
0.110
 Why?
Molecular Targeted Therapy
1
2014
121
0.110
 Why?
Phosphodiesterase 4 Inhibitors
1
2013
4
0.110
 Why?
Microscopy, Electron
2
2020
81
0.110
 Why?
Glomerular Filtration Rate
4
2017
114
0.110
 Why?
Translocation, Genetic
2
2005
263
0.110
 Why?
Organ Preservation
2
2024
29
0.110
 Why?
Sarcoidosis
1
2013
44
0.100
 Why?
Prospective Studies
2
2010
2414
0.100
 Why?
Cryoglobulinemia
1
2012
12
0.100
 Why?
Livedo Reticularis
1
2012
6
0.100
 Why?
Lipoprotein Lipase
1
2012
12
0.100
 Why?
DNA, Mitochondrial
2
2003
110
0.100
 Why?
Metalloporphyrins
1
2011
6
0.100
 Why?
Free Radical Scavengers
1
2011
25
0.100
 Why?
Cellular Microenvironment
1
2011
27
0.100
 Why?
Myocardium
2
2017
444
0.090
 Why?
Adrenal Cortex Neoplasms
1
2011
6
0.090
 Why?
Polymerase Chain Reaction
3
2008
456
0.090
 Why?
Triglycerides
1
2012
158
0.090
 Why?
Stilbenes
1
2011
54
0.090
 Why?
Tissue Array Analysis
2
2011
45
0.090
 Why?
Microscopy, Fluorescence
2
2014
164
0.090
 Why?
Peritoneal Neoplasms
1
2012
62
0.090
 Why?
Metalloendopeptidases
1
2011
69
0.090
 Why?
Hematuria
1
2010
26
0.090
 Why?
Fluorescent Antibody Technique
1
2010
112
0.090
 Why?
Ejaculatory Ducts
1
2010
3
0.090
 Why?
Plasma Cells
1
2012
221
0.090
 Why?
Seminal Vesicles
1
2010
13
0.090
 Why?
RNA, Messenger
4
2012
1101
0.080
 Why?
Hemodynamics
1
2011
266
0.080
 Why?
In Situ Hybridization
2
2006
64
0.080
 Why?
Antioxidants
1
2011
238
0.080
 Why?
Prostate
1
2010
117
0.080
 Why?
Epithelial Cells
2
2011
210
0.080
 Why?
Lymphatic Metastasis
1
2010
227
0.080
 Why?
Fatal Outcome
1
2009
195
0.080
 Why?
Survival Analysis
3
2017
671
0.080
 Why?
Iron Chelating Agents
1
2008
11
0.080
 Why?
Ligation
3
2014
62
0.080
 Why?
Nephritis, Interstitial
1
2008
9
0.080
 Why?
Benzoates
1
2008
22
0.080
 Why?
Microsatellite Repeats
1
2008
37
0.080
 Why?
Glomerular Mesangium
1
2008
7
0.070
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.070
 Why?
Mice, Inbred C57BL
5
2013
1785
0.070
 Why?
Loss of Heterozygosity
1
2008
77
0.070
 Why?
Basement Membrane
1
2008
18
0.070
 Why?
Triazoles
1
2008
112
0.070
 Why?
Cell Membrane
1
2008
249
0.070
 Why?
Glomerular Basement Membrane
1
2007
10
0.070
 Why?
Oxidative Stress
1
2011
763
0.070
 Why?
Mutation
2
2003
1292
0.070
 Why?
Kidney Pelvis
1
2006
17
0.070
 Why?
Prednisone
1
2007
101
0.070
 Why?
Paraffin Embedding
1
2006
52
0.070
 Why?
Karyotyping
3
2017
83
0.070
 Why?
Heart Diseases
1
2009
212
0.070
 Why?
Young Adult
4
2021
4064
0.070
 Why?
Nephrotic Syndrome
1
2006
18
0.070
 Why?
Clofibric Acid
1
2005
6
0.060
 Why?
Chromosomes, Human, Pair 2
1
2005
25
0.060
 Why?
Chromosomes, Human, Pair 7
1
2005
29
0.060
 Why?
Lipopolysaccharides
1
2006
196
0.060
 Why?
Anti-Bacterial Agents
1
2011
745
0.060
 Why?
Chromosomes, Human, Pair 5
1
2005
17
0.060
 Why?
Chromosomes, Human, Pair 9
1
2005
19
0.060
 Why?
Neurofibroma
1
2005
16
0.060
 Why?
Glucocorticoids
1
2007
230
0.060
 Why?
Fibroma
1
2005
39
0.060
 Why?
Foot
1
2005
40
0.060
 Why?
Blood Pressure
3
2011
529
0.060
 Why?
Protein Synthesis Inhibitors
1
2004
18
0.060
 Why?
Biopsy, Needle
1
2005
182
0.060
 Why?
Endodeoxyribonucleases
1
2004
44
0.060
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2005
122
0.060
 Why?
Adrenalectomy
1
2023
35
0.060
 Why?
Adrenal Glands
1
2023
40
0.060
 Why?
Vulva
1
2003
17
0.050
 Why?
Gene Expression Regulation, Enzymologic
1
2004
178
0.050
 Why?
Groin
1
2003
16
0.050
 Why?
RNA, Neoplasm
1
2003
45
0.050
 Why?
Proteasome Inhibitors
1
2024
104
0.050
 Why?
Time Factors
3
2014
2934
0.050
 Why?
Micromanipulation
1
2002
2
0.050
 Why?
Cytoplasm
1
2003
93
0.050
 Why?
Immunoenzyme Techniques
1
2003
141
0.050
 Why?
Biopsy, Fine-Needle
1
2003
108
0.050
 Why?
Blotting, Western
3
2012
587
0.050
 Why?
Perfusion
1
2002
48
0.050
 Why?
Rats
2
2024
3287
0.050
 Why?
Sodium Chloride
1
2002
58
0.050
 Why?
Neoplasm Invasiveness
2
2014
269
0.050
 Why?
Blood Flow Velocity
2
2013
100
0.050
 Why?
Sequence Analysis, DNA
1
2003
237
0.050
 Why?
Hypothermia, Induced
1
2002
39
0.050
 Why?
Mass Screening
1
2005
348
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
578
0.050
 Why?
Disease Models, Animal
3
2013
1419
0.050
 Why?
Capillary Permeability
2
2011
35
0.050
 Why?
Adolescent
3
2014
6475
0.050
 Why?
Bone Neoplasms
1
2003
179
0.050
 Why?
Hyperplasia
1
2021
96
0.050
 Why?
Transcription Factors
1
2004
566
0.040
 Why?
Liver
2
2019
1123
0.040
 Why?
Cell Differentiation
2
2014
651
0.040
 Why?
Clinical Laboratory Techniques
1
2020
30
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2021
256
0.040
 Why?
Heart Rate
2
2011
311
0.040
 Why?
Stress Fibers
1
2019
5
0.040
 Why?
Actin Depolymerizing Factors
1
2019
5
0.040
 Why?
rho-Associated Kinases
1
2019
20
0.040
 Why?
Treatment Outcome
3
2017
5230
0.040
 Why?
Carbon Tetrachloride
1
2019
22
0.040
 Why?
RNA, Viral
1
2020
123
0.040
 Why?
Child, Preschool
2
2011
3908
0.040
 Why?
Gene Knockdown Techniques
1
2019
106
0.040
 Why?
Cell Separation
1
2019
89
0.040
 Why?
Nitrites
2
2011
32
0.040
 Why?
Nitrates
2
2011
30
0.040
 Why?
Liver Neoplasms
1
2003
331
0.040
 Why?
Actins
1
2019
115
0.040
 Why?
Neutrophil Infiltration
2
2012
26
0.040
 Why?
Antibodies, Monoclonal
1
2003
462
0.040
 Why?
RNA Interference
1
2019
178
0.040
 Why?
RNA, Small Interfering
1
2019
210
0.040
 Why?
Cecum
2
2011
59
0.040
 Why?
Cell Movement
1
2019
246
0.040
 Why?
Cell Dedifferentiation
1
2018
9
0.040
 Why?
Wound Healing
1
2019
203
0.040
 Why?
Reactive Oxygen Species
2
2011
406
0.040
 Why?
Kidney Function Tests
1
2017
49
0.040
 Why?
Lung Neoplasms
1
2003
600
0.040
 Why?
Liver Cirrhosis
1
2019
229
0.030
 Why?
Microscopy, Video
2
2007
13
0.030
 Why?
Cell Line
1
2019
1010
0.030
 Why?
Nitric Oxide Synthase Type II
2
2007
65
0.030
 Why?
Acute Disease
2
2008
370
0.030
 Why?
Risk Factors
1
2005
3692
0.030
 Why?
Cardiomyopathy, Restrictive
1
2016
5
0.030
 Why?
Cysts
1
2016
51
0.030
 Why?
Genomics
1
2017
284
0.030
 Why?
Bone Marrow
1
2017
356
0.030
 Why?
Immunotherapy
1
2017
235
0.030
 Why?
Oxadiazoles
1
2014
10
0.030
 Why?
Permeability
1
2014
68
0.030
 Why?
Punctures
1
2014
49
0.030
 Why?
Thiophenes
1
2014
36
0.030
 Why?
Antigen-Antibody Complex
1
2014
35
0.030
 Why?
Terminology as Topic
1
2014
64
0.030
 Why?
Pyrazoles
1
2014
111
0.030
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2014
74
0.030
 Why?
Pyridines
1
2014
132
0.030
 Why?
Granuloma
1
2013
45
0.030
 Why?
Signal Transduction
1
2019
1625
0.030
 Why?
Bone Marrow Examination
1
2012
11
0.030
 Why?
Receptors, Lipoprotein
1
2012
7
0.030
 Why?
Azo Compounds
1
2012
10
0.030
 Why?
Angiopoietins
1
2012
5
0.030
 Why?
Peroxisome Proliferator-Activated Receptors
1
2012
14
0.030
 Why?
Plasma Exchange
1
2012
23
0.030
 Why?
Immunosuppressive Agents
1
2014
223
0.020
 Why?
Coloring Agents
1
2012
70
0.020
 Why?
Adipose Tissue, White
1
2012
34
0.020
 Why?
Prognosis
1
2017
1979
0.020
 Why?
Epithelium
1
2011
65
0.020
 Why?
Cystectomy
1
2012
49
0.020
 Why?
Cell Hypoxia
1
2011
82
0.020
 Why?
Child
2
2016
6877
0.020
 Why?
Superoxide Dismutase
1
2011
113
0.020
 Why?
Telemetry
1
2011
29
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1356
0.020
 Why?
Peritonitis
1
2011
27
0.020
 Why?
Multiple Organ Failure
1
2011
47
0.020
 Why?
Vasodilator Agents
1
2011
98
0.020
 Why?
Hypothermia
1
2011
34
0.020
 Why?
Hydroxamic Acids
1
2011
38
0.020
 Why?
Fluid Therapy
1
2011
75
0.020
 Why?
Oxidation-Reduction
1
2011
317
0.020
 Why?
Disease Progression
1
2013
823
0.020
 Why?
Interleukin-1beta
1
2011
73
0.020
 Why?
United States
1
2021
4913
0.020
 Why?
Body Weight
1
2012
514
0.020
 Why?
Animals, Newborn
1
2011
367
0.020
 Why?
Membrane Proteins
1
2012
348
0.020
 Why?
Gene Expression
1
2012
613
0.020
 Why?
Skin
1
2012
417
0.020
 Why?
Infant, Newborn
1
2016
2780
0.020
 Why?
Iron Overload
1
2008
8
0.020
 Why?
Cells, Cultured
1
2012
1589
0.020
 Why?
Erythrocyte Transfusion
1
2008
50
0.020
 Why?
Eosinophils
1
2008
41
0.020
 Why?
Drug Hypersensitivity
1
2008
37
0.020
 Why?
Myelodysplastic Syndromes
1
2008
79
0.020
 Why?
Rats, Sprague-Dawley
1
2011
1582
0.020
 Why?
NADP
1
2006
22
0.020
 Why?
Blood Urea Nitrogen
1
2006
40
0.020
 Why?
Lysine
1
2007
83
0.020
 Why?
Creatinine
1
2006
144
0.020
 Why?
Nuclease Protection Assays
1
2005
2
0.020
 Why?
Receptors, CCR5
1
2005
6
0.020
 Why?
Receptors, CCR1
1
2005
10
0.020
 Why?
Chemokine CCL5
1
2005
9
0.020
 Why?
Stress, Physiological
1
2006
174
0.020
 Why?
Receptors, Chemokine
1
2005
13
0.020
 Why?
Nitric Oxide
1
2007
259
0.020
 Why?
Vascular Cell Adhesion Molecule-1
1
2005
36
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2005
73
0.020
 Why?
Intercellular Adhesion Molecule-1
1
2005
61
0.020
 Why?
Muscle Neoplasms
1
2005
16
0.020
 Why?
PPAR alpha
1
2005
56
0.020
 Why?
Chemokines
1
2005
76
0.020
 Why?
Enzyme Inhibitors
1
2007
378
0.010
 Why?
Prostatectomy
1
2005
83
0.010
 Why?
Enzyme-Linked Immunosorbent Assay
1
2005
234
0.010
 Why?
Chromosome Mapping
1
2005
158
0.010
 Why?
Kidney Tubules, Proximal
1
2004
62
0.010
 Why?
Receptors, Cytoplasmic and Nuclear
1
2004
64
0.010
 Why?
Ligands
1
2004
203
0.010
 Why?
Cell Death
1
2004
174
0.010
 Why?
Pyrimidines
1
2005
193
0.010
 Why?
Antigens, CD
1
2005
216
0.010
 Why?
NF-kappa B
1
2005
315
0.010
 Why?
Tumor Necrosis Factor-alpha
1
2005
388
0.010
 Why?
Models, Genetic
1
2003
174
0.010
 Why?
Multigene Family
1
2002
56
0.010
 Why?
Infant
1
2011
3601
0.010
 Why?
Renal Artery Obstruction
1
2002
22
0.010
 Why?
Lasers
1
2002
107
0.010
 Why?
Mice, Knockout
1
2005
840
0.010
 Why?
Base Sequence
1
2003
657
0.010
 Why?
Polymorphism, Genetic
1
2002
181
0.010
 Why?
Cytokines
1
2005
606
0.010
 Why?
Models, Animal
1
2002
228
0.010
 Why?
Ischemia
1
2002
153
0.010
 Why?
Swine
1
2002
408
0.010
 Why?
Feasibility Studies
1
2002
386
0.010
 Why?
Laparoscopy
1
2002
170
0.010
 Why?
Gokden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (346) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department